Company Clinisan Srl with Fiscal Code 16831774
recorded a turnover of 2024 of
100.221,
with a net profit of
-3.732
and having an average number of employees of
8.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Clinisan Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
0
91.260
119.694
156.227
132.269
118.058
146.972
149.570
120.299
100.221
Total Income - EUR
0
91.260
119.694
156.227
132.269
125.259
147.237
149.570
120.360
104.197
Total Expenses - EUR
0
28.119
40.609
76.306
83.901
78.298
73.305
80.796
86.849
104.922
Gross Profit/Loss - EUR
0
63.141
79.085
79.921
48.368
46.961
73.932
68.774
33.511
-725
Net Profit/Loss - EUR
0
62.229
77.888
78.359
47.045
45.801
72.638
67.278
32.307
-3.732
Employees
0
6
8
9
9
8
8
8
8
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -16.2%, from 120.299 euro in the year 2023, to 100.221 euro in 2024.
The Net Profit decreased by -32.127 euro, from 32.307 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Clinisan Srl
Financial Rating - CLINISAN SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Clinisan Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Clinisan Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Clinisan Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
64.717 euro in 2024 which includes Inventories of
0 euro, Receivables of
22.798 euro and cash availability of
41.919 euro.
The company's Equity was valued at
47.686 euro, while total Liabilities amounted to
112.979 euro.
Equity decreased by -64.042 euro, from 112.356 euro in 2023, to 47.686 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Clinisan Srl